Maintain buy on NTPC as the government allots previously de-allocated coal blocks to NTPC.
We retain ‘buy’ on Glenmark Pharmaceuticals and value the stock on a sum-of-the-parts basis to reach our target…
Solid defensive growth prospects, sustainable competitive strength afford a premium
Reiterate ‘buy’ on Just Dial with a target price of R1,930 (earlier R1,985).
Efforts to boost output bodes well; road map of rail links build-out to help more
In our downgrade note ITC – Heading into a period of slower growth, we highlighted how consistent and large price…
Jubilant Lifesciences had multiple headwinds in FY15: a) The CMO business was adversely impacted by remediation measures and plant…
Inhaler launch an incremental positive; no significant increase in earnings seen near term
We maintain a ?buy? rating on NTPC with a target price of Rs 157 per share…
We maintain buy rating on Coal India (CIL) with a target price of R443 a share.
The strength accounts for $90 million in sales with only Ranbaxy and the innovator Aqua Pharm.
Similar to other oil marketing companies, IOC also reported Q3 losses…
It is hard to find any excitement in RCom?s Q3 results…
Adani Ports’ Q3 earnings were mixed while on positive side, the company continues to deliver strong volume growth.
We maintain reduce on Adani Power (APL) with a target price of Rs 35.
Sector in danger of seeing a significant slowdown
ICICI Bank reported PAT of Rs 2,270 crore for Q1, in line with our estimate of Rs 2,320 crore (Street…
Dabur?s Q1FY14 numbers were in line with expectations with volume growth of 9% y-o-y in the domestic business.
